GO-2D: identifying 2-dimensional cellular-localized functional modules in Gene Ontology

Jing Zhu; Jing Wang; Zheng Guo; Min Zhang; Da Yang; Yanhui Li; Dong Wang; Guohua Xiao
January 2007
BMC Genomics;2007, Vol. 8, p30
Academic Journal
Background: Rapid progress in high-throughput biotechnologies (e.g. microarrays) and exponential accumulation of gene functional knowledge make it promising for systematic understanding of complex human diseases at functional modules level. Based on Gene Ontology, a large number of automatic tools have been developed for the functional analysis and biological interpretation of the high-throughput microarray data. Results: Different from the existing tools such as Onto-Express and FatiGO, we develop a tool named GO-2D for identifying 2-dimensional functional modules based on combined GO categories. For example, it refines biological process categories by sorting their genes into different cellular component categories, and then extracts those combined categories enriched with the interesting genes (e.g., the differentially expressed genes) for identifying the cellular-localized functional modules. Applications of GO-2D to the analyses of two human cancer datasets show that very specific disease-relevant processes can be identified by using cellular location information. Conclusion: For studying complex human diseases, GO-2D can extract functionally compact and detailed modules such as the cellular-localized ones, characterizing disease-relevant modules in terms of both biological processes and cellular locations. The application results clearly demonstrate that 2-dimensional approach complementary to current 1-dimensional approach is powerful for finding modules highly relevant to diseases.


Related Articles

  • Parallel Single Cancer Cell Whole Genome Amplification Using Button-Valve Assisted Mixing in Nanoliter Chambers. Yang, Yoonsun; Swennenhuis, Joost F.; Rho, Hoon Suk; Le Gac, Séverine; Terstappen, Leon W. M. M. // PLoS ONE;Sep2014, Vol. 9 Issue 9, p1 

    The heterogeneity of tumor cells and their alteration during the course of the disease urges the need for real time characterization of individual tumor cells to improve the assessment of treatment options. New generations of therapies are frequently associated with specific genetic alterations...

  • Use of genome-wide association studies for drug repositioning. Sanseau, Philippe; Agarwal, Pankaj; Barnes, Michael R; Pastinen, Tomi; Richards, J Brent; Cardon, Lon R; Mooser, Vincent // Nature Biotechnology;Apr2012, Vol. 30 Issue 4, p317 

    The article focuses on a study on the potential application of genome-wide association studies (GWAS) in drug repositioning. The utility of GWAS in systematically identifying alternative or refined indications for existing drugs is assessed. A list of GWAS genes associated with disease traits is...

  • Ontology-driven indexing of public datasets for translational bioinformatics. Shah, Nigam H.; Jonquet, Clement; Chiang, Annie P.; Butte, Atul J.; Rong Chen; Musen, Mark A. // BMC Bioinformatics;2009 Supplement 2, Vol. 10, Special section p1 

    The volume of publicly available genomic scale data is increasing. Genomic datasets in public repositories are annotated with free-text fields describing the pathological state of the studied sample. These annotations are not mapped to concepts in any ontology, making it difficult to integrate...

  • The Disease Ontology: fostering interoperability between biological and clinical human disease-related data. Schriml, Lynn; Mitraka, Elvira // Mammalian Genome;Oct2015, Vol. 26 Issue 9/10, p584 

    The Disease Ontology (DO) enables cross-domain data integration through a common standard of human disease terms and their etiological descriptions. Standardized disease descriptors that are integrated across mammalian genomic resources provide a human-readable, machine-interpretable,...

  • Identification of Multiple Subcellular Locations for Proteins in Budding Yeast. Si-Bao Wan; Le-Le Hu; Sheng Niu; Kai Wang; Yu-Dong Cai; Wen-Cong Lu; Kuo-Chen Chou // Current Bioinformatics;Mar2011, Vol. 6 Issue 1, p71 

    Knowing the subcellular locations of a protein helps to explore its functions in vivo since a protein can only play its roles properly if and only if it is located at certain subcellular compartments. Since it is both time-consuming and costly to determine protein subcellular localization purely...

  • Structural and functional properties of genes involved in human cancer. Furney, Simon J; Higgins, Desmond G; Ouzounis, Christos A; Lopez-Bigas, Nuria // BMC Genomics;2006, Vol. 7, p3 

    Background: One of the main goals of cancer genetics is to identify the causative elements at the molecular level leading to cancer. Results: We have conducted an analysis of a set of genes known to be involved in cancer in order to unveil their unique features that can assist towards the...

  • Pathobiologic implications of methylation and expression status of Runx3 and CHFR genes in gastric cancer. Shi-Lian Hu; Da-Bing Huang; Yu-Bei Sun; Lei Wu; Wei-Ping Xu; Shi Yin; Jiong Chen; Xiao-Dong Jiang; Gan Shen // Medical Oncology;Jun2011, Vol. 28 Issue 2, p447 

    Runx3 and CHFR genes were defined as tumor suppressor genes in gastric cancer (GC) recently. This paper was to investigate the roles of methylation and expression status of Runx3 and CHFR genes in GC patients. Methylation-specific polymerase chain reaction (MSP) and bisulfite DNA sequencing...

  • Common genetic variants at the CRAC1 (HMPS) locus on chromosome 15q13.3 influence colorectal cancer risk. Jaeger, Emma; Webb, Emily; Howarth, Kimberley; Carvajal-Carmona, Luis; Rowan, Andrew; Broderick, Peter; Walther, Axel; Spain, Sarah; Pittman, Alan; Kemp, Zoe; Sullivan, Kate; Heinimann, Karl; Lubbe, Steven; Domingo, Enric; Barclay, Ella; Martin, Lynn; Gorman, Maggie; Chandler, Ian; Vijayakrishnan, Jayaram; Wood, Wendy // Nature Genetics;Jan2008, Vol. 40 Issue 1, p26 

    We mapped a high-penetrance gene (CRAC1; also known as HMPS) associated with colorectal cancer (CRC) in the Ashkenazi population to a 0.6-Mb region on chromosome 15 containing SCG5 (also known as SGNE1), GREM1 and FMN1. We hypothesized that the CRAC1 locus harbored low-penetrance variants that...

  • Comprehensive serial analysis of gene expression of the cervical transcriptome. Shadeo, Ashleen; Chari, Raj; Vatcher, Greg; Campbell, Jennifer; Lonergan, Kim M; Matisic, Jasenka; van Niekerk, Dirk; Ehlen, Thomas; Miller, Dianne; Follen, Michele; Lam, Wan L; MacAulay, Calum // BMC Genomics;2007, Vol. 8, p142 

    Background: More than half of the approximately 500,000 women diagnosed with cervical cancer worldwide each year will die from this disease. Investigation of genes expressed in precancer lesions compared to those expressed in normal cervical epithelium will yield insight into the early stages of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics